RhEumatoid Arthritis MEDIcation Adherence

Inclusion Criteria: * Patient with diagnosed rheumatoid arthritis (RA), * Patient, male or female, aged 18 or over, * Patient hospitalized or coming for a consultation in a rheumatology department, and returned home at hospital discharge * Patient having DMARDs for RA (continuation or initiation) comprising at least methotrexate and/or a tsDMARD (targeted synthetic DMARD, JAK inhibitor) and/or subcutaneous bDMARD (biologic DMARD), * Autonomous patient in the management of his drug treatment, * Patient understanding and speaking French, * Patient affiliated to the French general national health insurance or similar, * Patient having given his free, informed and signed consent. Exclusion Criteria: * Patient whose usual pharmacy already has or has had a patient included in the INTERVENTION group in the study, * Patient whose regular pharmacy is currently treating another patient. * Patient with obvious significant cognitive or psychiatric disorders incompatible with the study (according to the judgment of the investigator), * Patient whose management of his drug treatment at home is carried out exclusively by a carer, * Patient participating in another research that may interfere (investigator's judgement) with the results of the present study, * Adult patient protected under the terms of the law (Public Health Code), * Patient not fit to carry out the follow-up, according to the judgment of the investigator, * Pregnant or breastfeeding women.